[go: up one dir, main page]

MXPA03001643A - Composiciones y metodos para el diagnostico y tratamiento de tumores. - Google Patents

Composiciones y metodos para el diagnostico y tratamiento de tumores.

Info

Publication number
MXPA03001643A
MXPA03001643A MXPA03001643A MXPA03001643A MXPA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A
Authority
MX
Mexico
Prior art keywords
compositions
tumor
diagnosis
treatment
methods
Prior art date
Application number
MXPA03001643A
Other languages
English (en)
Inventor
Paul J Godowski
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/en
Priority claimed from PCT/US2001/017800 external-priority patent/WO2001093983A1/en
Priority claimed from PCT/US2001/019692 external-priority patent/WO2002000690A2/en
Priority claimed from PCT/US2001/021066 external-priority patent/WO2002008288A2/en
Priority claimed from PCT/US2001/021735 external-priority patent/WO2002008284A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MXPA03001643A publication Critical patent/MXPA03001643A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se dirige a composiciones de materia util para el diagnostico y tratamiento de tumores en mamiferos y a metodos para utilizar estas composiciones de materia para lo mismo.
MXPA03001643A 2000-08-24 2001-08-23 Composiciones y metodos para el diagnostico y tratamiento de tumores. MXPA03001643A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017800 WO2001093983A1 (en) 2000-06-02 2001-06-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/019692 WO2002000690A2 (en) 2000-06-23 2001-06-20 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
PCT/US2001/021066 WO2002008288A2 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/021735 WO2002008284A2 (en) 2000-07-20 2001-07-09 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
PCT/US2001/026626 WO2002016602A2 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
MXPA03001643A true MXPA03001643A (es) 2004-05-14

Family

ID=27567433

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001643A MXPA03001643A (es) 2000-08-24 2001-08-23 Composiciones y metodos para el diagnostico y tratamiento de tumores.

Country Status (5)

Country Link
JP (1) JP2004520810A (es)
AU (2) AU2001286785B2 (es)
CA (1) CA2420193A1 (es)
MX (1) MXPA03001643A (es)
WO (1) WO2002016602A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) * 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2481507A1 (en) * 2002-04-16 2003-10-30 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2305710A3 (en) * 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
SI1546182T1 (sl) * 2002-09-11 2011-04-29 Genentech Inc Sestavki in postopki za diagnozo in zdravljenje tumorja
WO2004060270A2 (en) * 2002-10-18 2004-07-22 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2511013A1 (en) * 2002-12-20 2004-07-15 Biogen Idec Ma Inc. Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
CA2530884C (en) 2003-07-02 2016-01-12 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
KR20070036089A (ko) 2004-07-02 2007-04-02 제넨테크, 인크. 비호지킨 림프종의 치료 방법 및 치료 조성물
JP4547533B2 (ja) * 2004-12-15 2010-09-22 独立行政法人産業技術総合研究所 核酸分解酵素
WO2006082851A1 (ja) * 2005-02-02 2006-08-10 The University Of Tokyo エピグリカニン関連ムチン
IL282783B2 (en) * 2006-05-18 2023-09-01 Caris Mpi Inc A system and method for determining a personalized medical intervention for a disease stage
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
WO2009015842A2 (en) * 2007-07-27 2009-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
ES2543201T3 (es) 2007-12-26 2015-08-17 Biotest Ag Métodos y agentes que mejoran la dirección a las células tumorales que expresan CD138
HUE024291T2 (en) 2007-12-26 2016-01-28 Biotest Ag Immunoconjugates and Applications for CD138
PL2238168T3 (pl) 2007-12-26 2014-11-28 Biotest Ag Środki które mają za cel CD138 i ich zastosowania
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3909799A1 (de) * 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
JP2002502605A (ja) * 1998-02-09 2002-01-29 ジェンセット 分泌タンパク質をコードするｃＤＮＡ
EP1490386B1 (en) * 1998-03-10 2008-08-13 Genentech, Inc. Novel polypeptide and nucleic acids encoding the same
NZ510464A (en) * 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
JP2002527757A (ja) * 1998-10-19 2002-08-27 ダイアデクスアス・インコーポレーテッド 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法

Also Published As

Publication number Publication date
WO2002016602A2 (en) 2002-02-28
JP2004520810A (ja) 2004-07-15
WO2002016602A3 (en) 2003-02-06
AU8678501A (en) 2002-03-04
AU2001286785B2 (en) 2006-08-17
CA2420193A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
EP1445317A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
EP2067472A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004112829A3 (en) Compositions and methods for the diagnosis and treatment of tumors of glial origin
NZ335981A (en) Ketobenzamides as calpain inhibitors
WO2005049075A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
SI1546182T1 (sl) Sestavki in postopki za diagnozo in zdravljenje tumorja
WO2005063299A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
CA2408541A1 (en) Treating eczema and/or psoriasis
IL150125A0 (en) Novel compounds
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA05008293A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
AU6871501A (en) Cgi-69 compositions and methods of use
WO2003053334A3 (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
FA Abandonment or withdrawal